From embryo study to cancer research

 In News

Flogentec, biotechnology company, expert in design and manufacturing of biology automated devices, started, after many years of R&D, her first own product. This new generation automaton, allows doing in situ hybridization and immunohistochimistry techniques into optimal conditions and in record times.

These complex protocols are used to define localization and expression of specific genes into wholemount samples. These experiments are, since a long time, used in the field of developmental research, specifically to understand the formation of different organs into embryos (i.e. neural plate formation).


The multiple number of international research against cancer and the evolution of biological techniques since the past 10 years, allows identifying genes and proteins expressed in individual with certain cancer. Immunohistochimistry and in situ hybridization are more and more uses to check the presence or absence of these proteins in patients.

Thanks to the automation and the faster getting results, Flo 400 becomes an important device for cancer research laboratories, and obviously, also for diagnostic laboratories.

These new perspectives of diagnostic aids motivate Flogentec to continue innovation search into his R&D department.

Recent Posts
Flo400 Un automate ultra rapide dédié à la détection in situ 3D